Free Trial

Thomson Reuters (TSE:TRI) Reaches New 12-Month High - Time to Buy?

Thomson Reuters logo with Industrials background

Thomson Reuters Co. (TSE:TRI - Get Free Report) NYSE: TRI's share price hit a new 52-week high on Tuesday . The company traded as high as C$274.18 and last traded at C$273.84, with a volume of 285265 shares trading hands. The stock had previously closed at C$271.15.

Wall Street Analyst Weigh In

Several equities research analysts have commented on TRI shares. Canaccord Genuity Group boosted their price objective on Thomson Reuters from C$175.00 to C$181.00 and gave the stock a "hold" rating in a research note on Friday, May 2nd. Bank of America set a C$255.00 price target on Thomson Reuters and gave the stock a "neutral" rating in a research note on Thursday, April 10th. BMO Capital Markets increased their price objective on Thomson Reuters from C$265.00 to C$280.00 and gave the company an "outperform" rating in a research note on Friday, May 2nd. Finally, Scotiabank cut shares of Thomson Reuters from a "strong-buy" rating to a "hold" rating in a research note on Friday, May 2nd. Five analysts have rated the stock with a hold rating, two have issued a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus target price of C$252.40.

View Our Latest Analysis on TRI

Thomson Reuters Stock Performance

The company has a debt-to-equity ratio of 24.28, a current ratio of 0.94 and a quick ratio of 0.52. The stock has a market cap of C$85.88 billion, a price-to-earnings ratio of 40.94, a PEG ratio of 3.64 and a beta of 0.40. The firm has a fifty day moving average of C$265.33 and a 200 day moving average of C$250.31.

Insider Activity at Thomson Reuters

In related news, Senior Officer Mary Alice Vuicic sold 8,621 shares of the stock in a transaction that occurred on Wednesday, June 18th. The stock was sold at an average price of C$269.21, for a total value of C$2,320,816.31. Also, Director Heather Anne O'hagan sold 875 shares of the firm's stock in a transaction on Wednesday, May 21st. The stock was sold at an average price of C$267.45, for a total value of C$234,019.98. Following the sale, the director directly owned 631 shares of the company's stock, valued at approximately C$168,761.83. This trade represents a 58.10% decrease in their position. Insiders sold 29,227 shares of company stock valued at $7,571,100 over the last ninety days. Corporate insiders own 69.76% of the company's stock.

About Thomson Reuters

(Get Free Report)

Thomson Reuters Corporation engages in the provision of business information services in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in five segments: Legal Professionals, Corporates, Tax & Accounting Professionals, Reuters News, and Global Print. The Legal Professionals segment offers research and workflow products focusing on legal research and integrated legal workflow solutions that combine content, tools, and analytics to law firms and governments.

Recommended Stories

Should You Invest $1,000 in Thomson Reuters Right Now?

Before you consider Thomson Reuters, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Thomson Reuters wasn't on the list.

While Thomson Reuters currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 “Boring” Mega Cap Stocks to Turn Into Pure Profit
Joby vs. Archer: The $10 Billion eVTOL Battle
3 Small-Cap Biotech Stocks With Catalysts Too Big to Ignore

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines